Most bought healthcare stocks in Q4 2019
See which Healthcare stocks institutional investors increased the most in Q4 2019, measured as net growth in reported share positions from Q3 2019 into Q4 2019. Notable additions at the top of this list include BRISTOL-MYERS SQUIBB CO (BMY), AVANTOR INC (AVTR), PFIZER INC (PFE), ABBOTT LABORATORIES (ABT). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 21,638,598 | $2.70B | 5 | 5 | 7 | 0 | 17 |
| AVTR | AVANTOR INC | 14,833,078 | $296.38M | 2 | 1 | 0 | 0 | 3 |
| PFE | PFIZER INC | 11,671,872 | $528.11M | 4 | 4 | 6 | 1 | 14 |
| ABT | ABBOTT LABORATORIES | 8,426,662 | $743.32M | 1 | 2 | 2 | 0 | 10 |
| BSX | BOSTON SCIENTIFIC CORP | 8,081,786 | $436.36M | 1 | 1 | 2 | 0 | 5 |
| BHC | BAUSCH HEALTH COS INC | 6,788,536 | $438.44M | 1 | 1 | 2 | 0 | 5 |
| ABBV | ABBVIE INC | 4,488,739 | $497.19M | 0 | 3 | 4 | 0 | 9 |
| A | AGILENT TECHNOLOGIES INC | 3,299,824 | $333.84M | 1 | 1 | 2 | 0 | 5 |
| GILD | GILEAD SCIENCES INC | 3,257,022 | $284.36M | 0 | 6 | 2 | 0 | 10 |
| EXEL | EXELIXIS INC | 3,104,330 | $53.73M | 0 | 1 | 0 | 0 | 1 |
| UNH | UNITEDHEALTH GROUP INC | 2,871,828 | $2.43B | 5 | 5 | 9 | 1 | 21 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,454,100 | $272.94M | 1 | 0 | 3 | 0 | 4 |
| ALKS | ALKERMES PLC | 1,735,545 | $39.77M | 0 | 1 | 0 | 0 | 1 |
| DXCM | DEXCOM INC | 1,703,738 | $376.53M | 1 | 1 | 0 | 0 | 2 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 1,479,970 | $239.27M | 0 | 2 | 0 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 1,382,595 | $6.02M | 0 | 1 | 0 | 0 | 1 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,277,465 | $566.93M | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 1,244,005 | $1.77M | 0 | 1 | 0 | 0 | 1 |
| OMI | OWENS & MINOR INC | 1,240,216 | $5.61M | 0 | 1 | 0 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | 1,223,079 | $25.47M | 1 | 1 | 1 | 0 | 4 |
| MRK | MERCK & CO. INC. | 1,128,447 | $170.67M | 3 | 6 | 6 | 0 | 18 |
| TGTX | TG THERAPEUTICS INC | 1,070,706 | $12.48M | 0 | 1 | 0 | 0 | 1 |
| MCK | MCKESSON CORP | 1,014,426 | $153.94M | 2 | 3 | 1 | 1 | 6 |
| ACRS | ACLARIS THERAPEUTICS INC | 813,581 | $3.13M | 0 | 1 | 0 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | 764,416 | $252.25M | 0 | 1 | 1 | 0 | 2 |
| CERS | CERUS CORP | 761,556 | -$4.91M | 1 | 1 | 0 | 0 | 2 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 752,617 | $3.85M | 0 | 1 | 0 | 0 | 2 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 735,272 | $79.10M | 0 | 1 | 0 | 0 | 1 |
| INVA | INNOVIVA INC | 729,610 | $42.29M | 0 | 2 | 0 | 0 | 2 |
| GH | GUARDANT HEALTH INC | 717,329 | $102.83M | 0 | 2 | 0 | 1 | 2 |
| INCY | INCYTE CORP | 715,172 | $151.54M | 0 | 3 | 1 | 0 | 4 |
| XRAY | DENTSPLY SIRONA INC | 702,235 | $68.93M | 0 | 1 | 3 | 1 | 4 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 667,637 | $9.29M | 0 | 1 | 0 | 0 | 1 |
| CMRX | CHIMERIX INC | 654,509 | $593.00K | 0 | 1 | 0 | 0 | 1 |
| ACAD | ACADIA PHARMACEUTICALS INC | 645,200 | $28.18M | 0 | 1 | 0 | 0 | 1 |
| BAX | BAXTER INTERNATIONAL INC | 642,476 | -$13.96M | 1 | 1 | 2 | 0 | 6 |
| SEM | SELECT MEDICAL HOLDINGS CORP | 630,900 | $16.37M | 0 | 1 | 0 | 0 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 629,919 | $2.30M | 0 | 1 | 0 | 0 | 1 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 625,510 | $1.40M | 0 | 1 | 1 | 0 | 2 |
| AUPH | AURINIA PHARMACEUTICALS INC | 622,317 | $12.77M | 1 | 1 | 0 | 0 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 586,384 | $431.00K | 0 | 1 | 0 | 0 | 1 |
| PCRX | PACIRA BIOSCIENCES INC | 582,238 | $35.16M | 0 | 1 | 0 | 0 | 1 |
| LXRX | LEXICON PHARMACEUTICALS INC | 537,799 | $2.99M | 0 | 1 | 0 | 0 | 1 |
| BIIB | BIOGEN INC | 536,094 | $467.05M | 3 | 2 | 1 | 2 | 7 |
| CTMX | CYTOMX THERAPEUTICS INC | 530,971 | $5.84M | 0 | 1 | 0 | 0 | 1 |
| VERU | VERU INC | 507,598 | $2.17M | 0 | 1 | 0 | 0 | 1 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 505,128 | $17.20M | 0 | 1 | 0 | 0 | 1 |
| BPMC | BLUEPRINT MEDICINES CORP | 504,902 | $45.77M | 0 | 1 | 0 | 0 | 1 |
| OVID | OVID THERAPEUTICS INC | 497,984 | $2.60M | 0 | 1 | 0 | 0 | 1 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | 459,634 | $1.51M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q4 2019
What are the most bought Healthcare stocks in Q4 2019?
The most bought healthcare stocks in Q4 2019 are those with the largest increase in reported share counts across institutional investors compared to Q3 2019, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2019?
Among filers in this sector, net additions were largest in companies such as BRISTOL-MYERS SQUIBB CO (BMY), AVANTOR INC (AVTR), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2019).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.